Technical note: Aberrant detection of cell surface Fas ligand with anti- peptide antibodies

Journal of Immunology

Volumn 160, Issue 9, 1998, Pages 4159-4160

  Smith, Dawn ^a   Sieg, Scott ^a   Kaplan, David ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; POLYCLONAL ANTIBODY;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL SURFACE; FLOW CYTOMETRY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; RABBIT;

ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; FAS LIGAND PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE GLYCOPROTEINS; PEPTIDE FRAGMENTS; RABBITS;

EID: 0032080637     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Sieg, S., Z. Yildirim, D. Smith, N. Kayagaki, H. Yagita, Y. Huang, and D. Kaplan. 1996. Herpes simplex virus type 2 inhibition of Fas ligand expression. J. Virol. 70:8747.
2. Sieg, S., D. Smith, Z. Yildirim, and D. Kaplan. 1997. Fas ligand deficiency in HIV disease. Proc. Natl. Acad. Sci. USA 94:5860.
3. Kayagaki N., A. Kawasaki, T. Ebata, H. Ohmoto, S. Ikeda, S. Inoue, K. Yoshino, K. Okumura, and H. Yagita. 1995. Metalloproteinase-mediated release of human Fas ligand. J. Exp. Med. 182:1777.
4. Tanaka, M., T. Suda, K. Haze, N. Nakmura, K. Sato, F. Kimura, K. Motoyoshi, M. Mizuki, S. Tagawa, S. Ohga, K. Hatake, A. Drummond, and S. Nagata. 1996. Fas ligand in human serum. Nat. Med. 2:317.
5. Saas P., P. R. Walker, M. Hahne, A. L. Quiquerez, V. Schnuriger, G. Perrin, L. French, E. G. Van Meir, N. de Tribolet, J. J. Tschopp, and P. Y. Dietrich. 1997. Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? J. Clin. Invest. 99:1173.
6. Kiener P. A., P. M. Davis, G. C. Starling, C. Mehlin, S. J. Klebanoff, J. A. Ledbetter, and W. C. Liles. 1997. Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages. J. Exp. Med. 185:1511.
7. Kiener P. A., P. M. Davis, B. M. Rankin, S. J. Klebanoff, J. A. Ledbetter, G. C. Starling, and W. C. Liles. 1997. Human monocytic cells contain high levels of intracellular Fas ligand: rapid release following cellular activation. J. Immunol. 159:1594.
8. Lee J. W., G. M. Gersuk, P. A. Kiener, C. Beckham, J. A. Ledbetter, and H. J. Deeg. 1997. HLA-DR-triggered inhibition of hemopoiesis involves Fas/Fas ligand interactions and is prevented by c-kit ligand. J. Immunol. 159:3211.
9. Berthou, C., L. Michel, A. Soulie, F. Jean-Louis, B. Flageul, L. Dubertret, F. Sigaux, Y. Zhang, and M. Sasportes. 1997. Acquisition of granzyme B and Fas ligand proteins by human keratinocytes contributes to epidermal cell defense. J. Immunol. 159:5293.
10. Giordano, C., G. Stassi, R. De Maria, M. Todaro, P. Richiusa, G. Papoff, G. Ruberti, M. Bagnasco, R. Testi, and A. Galluzzo. 1997. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275:960.
11. Zipp, F., R. Martin, R. Lichtenfels, W. Roth, J. Dichgans, P. H. Krammer, and M. Weller. 1997. Human autoreactive and foreign antigen-specific T cells resists apoptosis induced by soluble recombinant CD95 ligand. J. Immunol. 159:2108.
12. Hahne M., T. Renno, M. Schroeter, M. Irmler, L. French, T. Bornard, H. R. MacDonald, and J. J. Tschopp. 1996. Activated B cells express functional Fas ligand. Eur. J. Immunol. 26:721.
13. De Maria R., M. Boirivant, M. G. Cifone, P. Roncaioli, M. Hahne, J. J. Tschopp, F. Pallone. 1996. Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes: a potential role for the acidic sphingomyelinase pathway in normal immunoregulation. J. Clin. Invest. 97:316.
14. Mariani S. M., B. Matiba, C. Baumler, and P. H. Krammer. 1995. Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases. Eur. J. Immunol. 25:2303.